Table 1 Epidemiological and clinical characteristics of the patient cohort. Numbers in brackets give the number of patients with complete datasets with regards to the specific items
From: Safety and clinical impact of FEES – results of the FEES-registry
General characteristics (N = 2236) | |
|---|---|
Age | 69.8 (14.6) |
Female gender | 1013 (42.2) |
Barthel | 35 (35.4)) |
RASS | −0.1 (0.81) |
Anticoagulation | 451 (18.8) |
Anti-platelets | 796 (33.2) |
Antithrombotic drugs | 1005 (41.9) |
Specific characteristics (N = 2330) | |
Complex patients | 1089 (45.4) |
Respiratory problems | 279 (11.6) |
Tracheal cannula | 447 (18.6) |
Agitation | 161 (6.7) |
Disorientation | 496 (20.7) |
Fluctuating vigilance | 390 (16.2) |
Main Diagnosis (N = 2401) | |
Stroke | 1465 (61.0) |
Stroke with Thrombolysis | 393 (26.8) |
Parkinson’s Disease | 157 (6.5) |
Critical-Illness Polyneuropathy | 135 (5.6) |
Motorneuron Disorder | 75 (3.1) |
Dementia | 64 (2.7) |
Malignoma | 48 (2.0) |
Movenent Disorders (other) | 41 (1.7) |
Enzephalopathia | 37 (1.5) |
Traumatic Brain Injury | 36 (1.5) |
Meningitis/Enzephalitis | 36 (1.5) |
Myasthenia gravis | 35 (1.5) |
Immune-mediated neuropathy | 34 (1.4) |
Psychogenic dysphagia | 34 (1.4) |
Seizure | 33 (1.4) |
Myopathy | 29 (1.2) |
Cervical spine surgery | 20 (0.8) |
Multiple Sclerosis | 18 (0.7) |
Pneumonia | 13 (0.5) |
Esophageal diseases | 12 (0.5) |
Other/Missing | 79 (3.3) |